Monarch Medical Technologies, founded with a mission to revolutionize inpatient glycemic management, offers the EndoTool® Glucose Management System. This FDA-cleared digital health solution replaces traditional insulin dosing methods with an intuitive software application designed for both critical and non-critical care patients. Monarch's technology aims to enhance patient outcomes by providing personalized and predictive insulin dosing, seamlessly integrating into hospital workflows.

Notable figures associated with Monarch Medical Technologies include its leadership team and clinical advisory board, composed of experts in healthcare and technology. The company has garnered significant attention for its innovative approach, achieving FDA clearance for its flagship product. Monarch's impact is evident in its ability to improve glycemic control in hospitals, thereby enhancing patient safety and operational efficiency across healthcare enterprises.